Latest Regulatory News

Syntara Limited reports encouraging Phase 2a results for amsulostat in myelofibrosis, with significant symptom relief and spleen volume reduction sustained over 12 months, alongside new clinical trial initiations and a solid cash position.

Credit Corp Group has reaffirmed its FY26 guidance, highlighting robust earnings growth driven by operational improvements across its US debt buying and Australian/New Zealand lending segments.

Ramelius Resources has released a Definitive Feasibility Study for its Rebecca-Roe Gold Project, confirming strong economics with a post-tax NPV of A$692 million and average annual production of 130,000 ounces over nine years.

Auric Mining confirms its intent to acquire the Lindsay’s Gold Project, including the Parrot Feathers mine, with payments contingent on ongoing Wardens Court litigation outcomes.

Ardea Resources reports strong progress on its Kalgoorlie Nickel Project’s Definitive Feasibility Study, including high-grade drilling results, a heritage agreement, and consortium funding support. Completion of the DFS is now targeted for mid-2026 amid ongoing ESG and stakeholder engagement.

Sovereign Metals confirms its Kasiya Rutile-Graphite Project remains unaffected by Malawi’s new raw mineral export ban, thanks to its in-country processing plans.

Everest Metals Corporation has partnered with MEGA Resources and Bain Global Resources to fully fund and operate mining at the Mt Dimer Taipan Gold & Silver Project, with production set to begin imminently.

Moho Resources has significantly expanded its Bush Chook Gold Project in Western Australia, securing 26 new prospecting licences and unveiling high-grade gold assay results that set the stage for a substantial drilling program backed by a $2 million capital raise.

Australian Critical Minerals has completed a strategic acquisition of Circuit Resources, adding six multi-commodity projects in Peru and initiating exploration activities with drilling planned for late 2025.

Kingfisher Mining secures shareholder approval for NSW tenement acquisition and accelerates exploration at Copper Blow and Mick Well REE projects, backed by a solid $2.35 million cash position.

EMVision Medical Devices has expanded its pivotal clinical trial sites, secured a $3 million government grant, and raised $14 million through placement and share purchase plan, positioning itself strongly for upcoming regulatory submissions and commercialisation.

PT Aneka Tambang Tbk (ANTAM) reports robust nine-month 2025 financial results with significant profit growth, while navigating complex legal disputes and evolving mining regulations.